Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
CORNERSTONE
A ProspeCtive ObseRvatioNal Study of Atogepant Effectiveness in Routine Clinical Practice
1 other identifier
observational
1,000
14 countries
111
Brief Summary
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will evaluate the effectiveness of atogepant in treating adult participants with migraine in a real-world setting. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 1000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study across the world. Participants will receive atogepant oral tablets as prescribed per standard clinical practice and will be followed for 2 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Longer than P75 for all trials
111 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
February 13, 2026
February 1, 2026
4.2 years
August 6, 2024
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants Achieving a rating of "much better" or "very much better" as assessed by the Patient Global Impression of Change (PGI-C)
PGI-C is a single item used to measure the patient's impression of overall change in migraine since the first dose of atogepant. The measure uses a 7-point rating scale with responses ranging from "very much better" to "very much worse".
Week 12
Study Arms (1)
Atogepant
Participants will receive atogepant as prescribed by their physician in routine clinical practice.
Eligibility Criteria
Adult participants with migraine who are prescribed atogepant by their physician per routine standard of care
You may qualify if:
- At least 1-year history of migraine with or without aura consistent with a diagnosis according to the International Classification of Headache Disorders (ICHD)-3, 2018.
- Prescribed atogepant according to the relevant approved local label.
- For participants who initiate atogepant at the prescribing physician or treating health care provider (HCP) discretion as part of their routine clinical care, the decision to administer atogepant must be made prior to and independent of recruitment into the study.
- Willing and able to comply with the requirements of the study.
- Not on concomitant preventive medication for migraine or have been on a stable preventive medication for migraine for at least 3 months prior to enrollment in the study. If on a stable preventive medication, the prescribing physician or treating HCP and participant must confirm that there is no plan to change concomitant preventive medication during the first 12 weeks of the study.
You may not qualify if:
- Previously exposed to atogepant as routine therapy or from clinical trials experience prior to entry.
- Contraindications to atogepant as per local labeling.
- Pregnant or planning to be pregnant or women of childbearing potential not using contraception.
- Enrolled in any interventional studies that may include investigational compounds for migraine, or non-AbbVie observational studies.
- In the opinion of the prescribing physician or treating HCP, the participant has a history or current evidence of any condition that might interfere with patient's ability to comply with the study requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AbbVielead
Study Sites (111)
Neurology and Neurodiagnostics of Alabama /ID# 267614
Hoover, Alabama, 35244, United States
Rehabilitation & Neurological Services /ID# 267612
Huntsville, Alabama, 35805-4046, United States
Barrow Neurological Institute - Dignity Health St. Joseph's Hosp and Medical Ctr /ID# 267610
Phoenix, Arizona, 85013, United States
Kenneth Martinez MD, A Medical Corp /ID# 267834
Aliso Viejo, California, 92656, United States
Los Angeles Headache Center /ID# 267570
Los Angeles, California, 90067-2001, United States
Alcanza Clinical Research, LLC /ID# 267838
Lake Mary, Florida, 32746-2118, United States
Norton Cancer Institute - St. Matthews /ID# 267605
Louisville, Kentucky, 40207, United States
Dent Neurologic Institute - Amherst /ID# 267606
Amherst, New York, 14226, United States
Northwell Health - Great Neck /ID# 280705
Great Neck, New York, 11021, United States
Northwell Health /ID# 267596
New York, New York, 10022-1304, United States
Thomas Jefferson University Hospital /ID# 267572
Philadelphia, Pennsylvania, 19107, United States
Inova Health Care System /ID# 267615
Falls Church, Virginia, 22042, United States
Neuroscience Group /ID# 267571
Neenah, Wisconsin, 54956-1993, United States
Cliniques Universitaires UCL Saint-Luc /ID# 270545
Brussels, Brussels Capital, 1200, Belgium
Universitair Ziekenhuis Brussel /ID# 269799
Jette, Brussels Capital, 1090, Belgium
Chu Tivoli /ID# 271254
La Louvière, Hainaut, 7100, Belgium
Centre Hospitalier Régional de la Citadelle /ID# 270539
Liège, Liege, 4000, Belgium
Groupe Sante CHC - Clinique du MontLegia /ID# 270218
Liège, Liege, 4000, Belgium
OLV Ziekenhuis Aalst /ID# 270284
Aalst, Oost-Vlaanderen, 9300, Belgium
AZ Sint-Jan Brugge /ID# 270540
Bruges, West-Vlaanderen, 8000, Belgium
AZ Groeninge /ID# 272772
Kortrijk, West-Vlaanderen, 8500, Belgium
Calgary Headache Assessment and Management Program /ID# 270266
Calgary, Alberta, T3M 1M4, Canada
Burrard Health Center /ID# 270268
Vancouver, British Columbia, V6Z 2E8, Canada
Dr. Renju Kuriakose Prof. Corp. /ID# 273178
Saint John, New Brunswick, E2K 4P8, Canada
Maritime Neurology /ID# 270270
Halifax, Nova Scotia, B3R 1V9, Canada
Centricity /ID# 271478
London, Ontario, N6A 2C2, Canada
London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 270943
London, Ontario, N6A 5W9, Canada
Bayshore Neurology /ID# 270673
Ottawa, Ontario, K2B 8E8, Canada
Sunnybrook Health Sciences Centre /ID# 273207
Toronto, Ontario, M4N 3M5, Canada
Centre de Recherche St-Louis /ID# 270957
Lévis, Quebec, G6W 0M5, Canada
Genge Partners /ID# 270267
Montreal, Quebec, H4A 3T2, Canada
Universitaetsklinikum Heidelberg /ID# 278134
Heidelberg, Baden-Wurttemberg, 69120, Germany
Universitaetsklinikum Tuebingen /ID# 275762
Tübingen, Baden-Wurttemberg, 72076, Germany
Praxis fur Neurologie Dr. med. Martin Delf /ID# 275918
Hoppegarten, Brandenburg, 15366, Germany
Zentrum Für Klinische Forschung Dr. Irma Schöll /ID# 275642
Bad Homburg, Hesse, 61350, Germany
Evangelisches Krankenhaus Oldenburg /ID# 275823
Oldenburg, Lower Saxony, 26122, Germany
Universitaetsmedizin Greifswald /ID# 276678
Greifswald, Mecklenburg-Vorpommern, 17489, Germany
ZNS Siegen /ID# 275660
Siegen, North Rhine-Westphalia, 57076, Germany
Dres. Huhn-Doll/Siquet/Vocke /ID# 279583
Velbert, North Rhine-Westphalia, 42551, Germany
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 275759
Dresden, Saxony, 01307, Germany
Universitaetsklinikum Schleswig-Holstein - Campus Kiel /ID# 281667
Kiel, Schleswig-Holstein, 24105, Germany
Schmerzklinik Kiel /ID# 275592
Kiel, Schleswig-Holstein, 24149, Germany
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 275760
Berlin, 10117, Germany
Schmerzzentrum Berlin /ID# 275819
Berlin, 10435, Germany
Neurologischen Facharztzentrum Berlin /ID# 275919
Berlin, 10713, Germany
Städtisches Klinikum Brandenburg /ID# 275725
Brandenburg, 14770, Germany
IRCCS Ospedale San Raffaele /ID# 273153
Milan, Milano, 20132, Italy
Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 275269
Naples, Napoli, 80138, Italy
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 274426
Turin, Piedmont, 10126, Italy
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 274651
Rome, Roma, 00133, Italy
Sapienza University of Rome /ID# 273506
Rome, Roma, 00161, Italy
Azienda Ospedaliero Universitaria delle Marche /ID# 273349
Ancona, 60020, Italy
Policlinico di Bari Ospedale Giovanni XXIII /ID# 275336
Bari, 70126, Italy
Azienda Ospedaliero-Universitaria Renato Dulbecco /ID# 272696
Catanzaro, 88100, Italy
Fondazione Mondino Istituto Neurologico Nazionale a Carattere Scientifico IRCCS /ID# 273155
Pavia, 27100, Italy
Azienda Sanitaria Universitaria Giuliano Isontina - Trieste /ID# 274413
Trieste, 34128, Italy
Gelre Ziekenhuis /ID# 272429
Apeldoorn, Gelderland, 7334 DZ, Netherlands
Maxima Medisch Centrum, Locatie Veldhoven /ID# 270278
Veldhoven, North Brabant, 5504 DB, Netherlands
Zaans Medisch Centrum /ID# 269603
Zaandam, North Holland, 1502 DV, Netherlands
Isala, locatie Zwolle /ID# 269602
Zwolle, Overijssel, 8025 AB, Netherlands
Maasstad Ziekenhuis /ID# 269601
Rotterdam, South Holland, 3079 DZ, Netherlands
Hodeverket /ID# 271383
Sandnes, Rogaland, 4319, Norway
Oslo Hodepinesenter AS /ID# 271384
Oslo, 0275, Norway
Unidade Local de Saude do Alto Ave, EPE /ID# 274767
Guimarães, Braga District, 4835-044, Portugal
Hospital da Luz /ID# 267002
Lisbon, Lisbon District, 1500-650, Portugal
Unidade Local de Saude de Loures-Odivelas, EPE /ID# 274764
Loures, Lisbon District, 2674-514, Portugal
CUF Sintra Hospital /ID# 272394
Sintra, Lisbon District, 2710-204, Portugal
Campus Neurológico Sénior /ID# 272392
Torres Vedras, Lisbon District, 2560-280, Portugal
Hospital CUF Coimbra /ID# 272393
Coimbra, 3000-600, Portugal
Hospital CUF Porto /ID# 272788
Porto, 4100-180, Portugal
Hospital Regional Universitario de Malaga /ID# 268272
Málaga, Andalusia, 29010, Spain
Hospital Universitari de Bellvitge /ID# 268224
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario Severo Ochoa /ID# 268249
Leganés, Madrid, 28911, Spain
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 268246
Majadahonda, Madrid, 28222, Spain
Hospital Universitario Central de Asturias /ID# 276477
Oviedo, Principality of Asturias, 33011, Spain
Hospital Universitario Virgen Macarena /ID# 268244
Seville, Sevilla, 41009, Spain
Hospital Universitario Vall de Hebron /ID# 268222
Barcelona, 08035, Spain
Hospital Universitario de La Princesa /ID# 268245
Madrid, 28006, Spain
Hospital Universitario La Paz /ID# 268238
Madrid, 28046, Spain
Hospital Alvaro Cunqueiro /ID# 268248
Pontevedra, 36312, Spain
Hospital Universitario Virgen del Rocio /ID# 268223
Seville, 41013, Spain
Hospital Clinico Universitario de Valladolid /ID# 268225
Valladolid, 47003, Spain
Hospital Clinico Universitario Lozano Blesa /ID# 268243
Zaragoza, 50009, Spain
Karolinska Universitetssjukhuset - Huddinge /ID# 265295
Huddinge, Stockholm County, 141 57, Sweden
Neurology Clinic /ID# 266707
Stockholm, Stockholm County, 114 33, Sweden
Skaneuro /ID# 265203
Lund, 222 22, Sweden
NeuroPraxis Birseck /ID# 266140
Reinach, Basel-Landschaft, 4153, Switzerland
ZURZACH Care /ID# 265697
Bad Zurzach, Canton of Aargau, 5330, Switzerland
CHUV, Centre hospitalier universitaire vaudois /ID# 266551
Lausanne, Canton of Vaud, 1011, Switzerland
Kopfwehzentrum Hirslanden Zuerich /ID# 265817
Zollikon, Canton of Zurich, 8702, Switzerland
Neurozentrum Bellevue /ID# 277666
Zurich, Canton of Zurich, 8001, Switzerland
University Hospital Zurich /ID# 276450
Zurich, Canton of Zurich, 8091, Switzerland
DYA Swiss Institut SA /ID# 266891
Lugano, Canton Ticino, 6900, Switzerland
EOC Ospedale Regionale Lugano /ID# 266887
Lugano, Canton Ticino, 6900, Switzerland
Hôpital De Sion /ID# 276360
Sion, Valais, 1951, Switzerland
Inselspital, Universitaetsspital Bern /ID# 265818
Bern, 3010, Switzerland
Tri-Service General Hospital /ID# 272082
Taipei, 114, Taiwan
Linkou Chang Gung Memorial Hospital /ID# 272084
Taoyuan, 333, Taiwan
Harley Street Medical Centre /ID# 276430
Abu Dhabi, 000000, United Arab Emirates
American Center of Neurology and Psychiatry /ID# 276429
Abu Dhabi, United Arab Emirates
Hull Royal Infirmary /ID# 276819
Hull, East Riding Of Yorkshire, HU3 2JZ, United Kingdom
Western General Hospital - NHS Lothian /ID# 277029
Edinburgh, Edinburgh, City of, EH4 2XU, United Kingdom
Guy's Hospital /ID# 276817
London, Greater London, SE1 9RT, United Kingdom
King'S College Hospital /ID# 276818
London, Greater London, SE5 9RS, United Kingdom
Cripps Health Centre /ID# 277474
Nottingham, Nottinghamshire, NG7 2QW, United Kingdom
University Hospitals North Midlands - Royal Stoke University Hospital /ID# 276821
Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom
Leeds Teaching Hospitals NHS Trust /ID# 279417
Leeds, West Yorkshire, LS9 7TF, United Kingdom
Great Western Hospital /ID# 276693
Swindon, Wiltshire, SN3 6BB, United Kingdom
Worcestershire Royal Hospital /ID# 276902
Worcester, Worcestershire, WR5 1DD, United Kingdom
Ulster Hospital - South Eastern Health & Social Care Trust /ID# 276900
Belfast, BT16 1RH, United Kingdom
University Hospital of Wales /ID# 276822
Cardiff, CF14 4XW, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ABBVIE INC.
AbbVie
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2024
First Posted
August 9, 2024
Study Start
November 26, 2024
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
February 1, 2029
Last Updated
February 13, 2026
Record last verified: 2026-02